Last updated: November 17, 2025
Sponsor: University Hospital of North Norway
Overall Status: Completed
Phase
4
Condition
Urologic Cancer
Prostate Cancer
Prostate Cancer, Early, Recurrent
Treatment
Spinal Anesthesia with Bupivacaine
Placebo
Clinical Study ID
NCT06860893
Prostate REK 866656
Ages 18-80 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Prostate cancer
Exclusion
Exclusion Criteria:
- Benign prostate disease
Study Design
Total Participants: 30
Treatment Group(s): 2
Primary Treatment: Spinal Anesthesia with Bupivacaine
Phase: 4
Study Start date:
February 28, 2025
Estimated Completion Date:
September 20, 2025
Study Description
Connect with a study center
University Hospital of North Norway
Tromso, 9038
NorwaySite Not Available
University Hospital of North Norway
Tromsø 3133895, 9038
NorwaySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.